Coordinated scientific advice for health product R&D
20 September 2023
| Technical document
Overview
The World Health Organization offers coordinated scientific advice to external parties to support the development of appropriate health products in areas of unmet public health needs.
The WHO Coordinated Scientific Advice (CSA) procedure enables product developers with health products approaching late-stage trials to receive written advice that reflects WHO’s technical stance on the clinical development plan and on quality and evidence requirements to satisfy WHO Prequalification and policy development processes.
WHO Team
Research for Health (RFH)
Editors
World Health Organization
Number of pages
4
Reference numbers
WHO Reference Number: WHO/SCI/RFH/2023.7